 |

David M. Tanen, Partner
Mr. Tanen is a co-founder and Partner of Two River. He currently serves
as Vice President of Two River's managing member and also serves as an
Officer and Director of Riverbank Capital Securities, Inc., a FINRA
member broker dealer ("Riverbank"). From October 1996 to September
2004, Mr. Tanen was a Director of Paramount where he co-founded a number
of development stage biotechnology companies. Mr. Tanen was responsible
for drafting and negotiating more than 30 license agreements for the
acquisition of novel technologies, as well as structuring and closing
private placement offerings. Mr. Tanen also served as a member of the
General Partner of the Orion Biomedical Fund, LP. Mr. Tanen currently
serves as an officer and director of Nile Therapeutics, Inc.
(NASDAQ:NLTX) and Arno Therapeutics, Inc. (OTCBB:LRRI.OB), each a
publicly reporting company, as well as Danube Pharmaceuticals, Inc., a
privately held ophthalmology company. Mr. Tanen received his B.A. from
The George Washington University and his J.D. from Fordham University
School of Law.
 |
 |